Trial Profile
A retrospective study of treating Her2+ advanced/metastatic breast cancer patients with lapatinib alone or in combination with capecitabine after trastuzumab progression
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Aug 2014
Price :
$35
*
At a glance
- Drugs Lapatinib (Primary) ; Antineoplastics; Capecitabine
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 13 Aug 2014 New trial record
- 03 Jun 2014 Results published at the 50th Annual Meeting of the American Society of Clinical Oncology.